Related Experiment Video

Updated: Jul 25, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Letter: years of life that could be saved by preventing HCC

A Ponzetto1, J Holton2, D Vaira3

  • 1Department of Medical Science, University of Turin, Torino, Italy.

Alimentary Pharmacology & Therapeutics
|December 10, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
05:25

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration

Published on: May 24, 2024

3.8K

Related Experiment Videos

Last Updated: Jul 25, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
05:25

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration

Published on: May 24, 2024

3.8K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Articles linked to this work by shared authors, journal, and citation graph.

Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023.

ESMO open·2024

First-line therapies for H. pylori infection in Italy: a pooled-data analysis.

Acta gastro-enterologica Belgica·2022

[The COVID-19 breaker : PCR to the rescue !]

Revue medicale de Liege·2020

[Hurdles to HIV cure. Part 1 : the latent reservoirs].

Revue medicale de Liege·2020

[Hurdles to HIV cure. Part 2 : ongoing HIV replication despite therapy].

Revue medicale de Liege·2020

Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients.

Antibiotics (Basel, Switzerland)·2020

Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study.

Alimentary pharmacology & therapeutics·2026

Treatment Patterns in Patients With Eosinophilic Oesophagitis Referred for Expert Consultation.

Alimentary pharmacology & therapeutics·2026

Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial.

Alimentary pharmacology & therapeutics·2026

Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Alimentary pharmacology & therapeutics·2026

Bowel Preparation in Quality Guidelines and Clinical Practice.

Alimentary pharmacology & therapeutics·2026

Modern Bowel Preparations, Clinical Evidence and Practical Advantages.

Alimentary pharmacology & therapeutics·2026

From screening to surveillance: integrated prevention of Helicobacter pylori-associated gastric cancer in the Asia-Pacific region.

The Lancet regional health. Western Pacific·2026

Cancer Screening Behaviors among People with HIV in the United States and the Role of Multi-Level Social and Economic Factors: A Systematic Review.

Current epidemiology reports·2026

Strengthening public understanding and prevention of dengue in Malaysia: insights and recommendations based on knowledge, attitudes, and practices toward vector control and vaccination.

Frontiers in public health·2026

Vaccine Policy: The State Role in a Time of Public Health Disruption.

The Milbank quarterly·2026

Perceived Feasibility and Acceptability of a Self-Collected HPV DNA Testing Policy for Cervical Cancer Screening in Thailand.

Journal of primary care & community health·2026

Self-Harm and Suicidal Ideation in Pregnancy: The Impact of Education on Knowledge, Confidence and Documentation Related to Screening and Follow-Up to Question Ten-Positive on the Edinburgh Postnatal Depression Scale.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us